Year: 2023
Type: article
Authors: Peter L. Bonate, Jeffrey S. Barrett, Sihem Ait-Oudhia, Richard Brundage, Brian Corrigan, Stephen Duffull, Marc Gastonguay, Mats O. Karlsson, Shinichi Kijima, Andreas Krause, Mark Lovern, Matthew M. Riggs, Michael Neely, Daniele Ouellet, Elodie L. Plan, Gauri G. Rao, Joseph Standing, Justin Wilkins, Hao Zhu
Institutions: Astellas Pharma (United States), Aridhia (United Kingdom), Merck & Co., Inc., Rahway, NJ, USA (United States), University of Minnesota, Pfizer (United States), University of Otago, Metrum Research Group (United States), Uppsala University, Pharmaceuticals and Medical Devices Agency, Idorsia Pharmaceuticals Ltd (Switzerland), University of Southern California, Children's Hospital Los Angeles, University of North Carolina at Chapel Hill, Great Ormond Street Hospital, University College London, United States Food and Drug Administration
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Medical Research Council
Award: G4573245717
OpenAlex ID: W4385786385